Opportunity Information: Apply for RFA AG 23 030
The NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award is a National Institutes of Health funding opportunity (RFA-AG-23-030) that uses the STTR mechanism under the R41/R42 "Industry Development Award" structure, with clinical trials listed as optional. Its central purpose is not just to advance a product-oriented research project, but to deliberately help early-career scientists build the skills, experience, and professional footing needed to move into industry and entrepreneurship. In practice, the program is designed to create a bridge from academic-style training into a small business environment by pairing research and development support with a substantial emphasis on entrepreneurial education, mentoring, and career development.
A defining feature of this FOA is that it encourages small business concerns (SBCs) to bring postdoctoral fellows and early-stage researchers into key leadership roles by supporting their hiring and salary as the project Principal Investigator/Program Director (PI/PD). The intent is twofold: to strengthen the company’s scientific workforce for product development and to accelerate the professional transition of the early-career PI/PD into an industry setting. The FOA specifically highlights postdocs and early-career researchers who already have strong research and technology discovery experience, but who want to develop an entrepreneurial skillset and pursue a career in the private sector, as the best-fit candidates to lead these projects.
Because the award is explicitly structured around the investigator’s transition into the small business, the FOA emphasizes that most of the PI/PD’s employment must be at the SBC. That requirement signals that this is not meant to be a lightly affiliated role while the investigator remains primarily in an academic appointment; instead, it is meant to anchor the investigator’s day-to-day work and professional development within the company environment where commercialization and product development are central priorities.
Eligibility is focused on small businesses as applicants. Foreign institutions (non-U.S. entities) are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible. However, foreign components as defined under the NIH Grants Policy Statement may be allowed, which typically means certain limited, well-justified elements of the work could potentially occur abroad under NIH policy, even though the applicant organization itself must be domestic and eligible.
Administratively, the opportunity is offered by the National Institutes of Health under CFDA 93.866 in the health funding category, and it is a discretionary grant. The original closing date listed for the opportunity was February 17, 2023. The posted award ceiling is $1,838,436, indicating the program can support relatively substantial development efforts when aligned with the FOA’s goals. Overall, the REDI Entrepreneurial Small Business Transition Award is best understood as an STTR-based pathway that deliberately couples product-focused R and D with structured entrepreneurial immersion, aiming to grow a capable industry-facing scientific leader while also advancing a commercialization-minded technology within a small business.Apply for RFA AG 23 030
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2022-07-06.
- Applicants must submit their applications by 2023-02-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,838,436.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: BJA FY 23 Second Chance Act Pay for Success Program
Previous opportunity: Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 23 030
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 23 030) also looked into and applied for these:
| Funding Opportunity |
|---|
| New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed) Apply for RFA HL 23 015 Funding Number: RFA HL 23 015 Agency: National Institutes of Health Category: Health Funding Amount: $373,000 |
| Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 22 213 Funding Number: PAR 22 213 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed) Apply for RFA HL 23 016 Funding Number: RFA HL 23 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 22 169 Funding Number: PAR 22 169 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional) Apply for RFA AG 23 021 Funding Number: RFA AG 23 021 Agency: National Institutes of Health Category: Health Funding Amount: $4,800,000 |
| Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed) Apply for RFA MH 22 281 Funding Number: RFA MH 22 281 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed) Apply for RFA MH 22 280 Funding Number: RFA MH 22 280 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 22 193 Funding Number: PAR 22 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 22 192 Funding Number: PAR 22 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 22 189 Funding Number: PAR 22 189 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required) Apply for RFA TR 22 029 Funding Number: RFA TR 22 029 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed) Apply for PAR 22 190 Funding Number: PAR 22 190 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Postdoctoral Research Associate Training (PRAT) Program (Fi2) Apply for PAR 22 191 Funding Number: PAR 22 191 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) Apply for PAR 22 212 Funding Number: PAR 22 212 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 046 Funding Number: RFA AI 22 046 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed) Apply for RFA AA 22 003 Funding Number: RFA AA 22 003 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed) Apply for RFA NS 22 055 Funding Number: RFA NS 22 055 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed) Apply for RFA NS 23 004 Funding Number: RFA NS 23 004 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 22 185 Funding Number: RFA MH 22 185 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Geroscience Course (R25 Independent Clinical Trial Not Allowed) Apply for PAR 22 214 Funding Number: PAR 22 214 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 23 030", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.